Association of Baseline Serum Levels of CXCL5 With the Efficacy of Nivolumab in Advanced Melanoma

Anti-programmed cell death protein 1 (PD1) antibodies are in wide use for the treatment of various cancers. PD1 antibody-based immunotherapy, co-administration of nivolumab and ipilimumab, is one of the optimal immunotherapies, especially in advanced melanoma with high tumor mutation burden. Since t...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Front Med (Lausanne)
Main Authors: Fujimura, Taku, Sato, Yota, Tanita, Kayo, Lyu, Chunbing, Kambayashi, Yumi, Amagai, Ryo, Otsuka, Atsushi, Fujisawa, Yasuhiro, Yoshino, Koji, Matsushita, Shigeto, Uchi, Hiroshi, Yamamoto, Yuki, Hata, Hiroo, Funakoshi, Takeru, Nonomura, Yumi, Tanaka, Ryota, Okuhira, Hisako, Wada, Naoko, Hashimoto, Akira, Aiba, Setsuya
Formato: Artigo
Idioma:Inglês
Publicado em: Frontiers Media S.A. 2019
Assuntos:
Medicine
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6497728/
https://ncbi.nlm.nih.gov/pubmed/31080803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fmed.2019.00086
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados